Pdgfrb‐Cre targets lymphatic endothelial cells of both venous and non‐venous origins

The Pdgfrb‐Cre line has been used as a tool to specifically target pericytes and vascular smooth muscle cells. Recent studies showed additional targeting of cardiac and mesenteric lymphatic endothelial cells (LECs) by the Pdgfrb‐Cre transgene. In the heart, this was suggested to provide evidence for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulvmar, Maria H., Martinez‐Corral, Ines, Stanczuk, Lukas, Mäkinen, Taija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Technology Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021155/
https://www.ncbi.nlm.nih.gov/pubmed/27060598
http://dx.doi.org/10.1002/dvg.22939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021155/
https://www.ncbi.nlm.nih.gov/pubmed/27060598
http://dx.doi.org/10.1002/dvg.22939

Ejemplares similares